- 全部删除
您的购物车当前为空
Donanemab (LY3002813) 是一种靶向 N 末端焦谷氨酸β淀粉样蛋白 (Aβ) 表位的人源化 IgG1 单克隆抗体,诱导的 tau 减慢,诱导淀粉样蛋白减少。Donanemab 可用于治疗早期阿尔茨海默症。
Donanemab (LY3002813) 是一种靶向 N 末端焦谷氨酸β淀粉样蛋白 (Aβ) 表位的人源化 IgG1 单克隆抗体,诱导的 tau 减慢,诱导淀粉样蛋白减少。Donanemab 可用于治疗早期阿尔茨海默症。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 2,320 | In stock | |
| 5 mg | ¥ 5,490 | In stock | |
| 10 mg | ¥ 7,480 | In stock | |
| 25 mg | ¥ 10,900 | In stock | |
| 50 mg | ¥ 14,800 | In stock | |
| 100 mg | ¥ 19,800 | In stock |
Donanemab 相关产品
| 产品描述 | Donanemab (LY3002813) is a humanized IgG1 monoclonal antibody targeting the N-terminal pyroglutamate β-amyloid (Aβ) epitope, which slows down tau and induces a reduction in amyloid.Donanemab can be used for the treatment of early Alzheimer's disease. |
| 别名 | 多纳单抗, LY3002813 |
| CAS No. | 1931944-80-7 |
| 颜色 | Transparent |
| 物理性状 | Liquid |
| 存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容